Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
OMIM | RCV000005509 | SCV000025691 | pathogenic | Chondrocalcinosis 2 | 2003-09-01 | no assertion criteria provided | literature only | |
Prevention |
RCV004734498 | SCV005363219 | likely pathogenic | ANKH-related disorder | 2024-09-17 | no assertion criteria provided | clinical testing | The ANKH c.13C>A variant is predicted to result in the amino acid substitution p.Pro5Thr. This variant has been reported to segregate with disease in two families with chondrocalcinosis (Williams et al. 2003. PubMed ID: 13130483). Additionally, alternate missense variants affecting this amino acid (p.Pro5Leu, p.Pro5Ser) have been reported as pathogenic (Williams et al. 2002. PubMed ID: 12297989; Gruber et al. 2012. PubMed ID: 22647861). This variant has not been reported in a large population database, indicating this variant is rare. This variant is interpreted as likely pathogenic. |